Classification of lymphoma in cats and its relationship with the detection of feline leukemia vírus proviral DNA / Classificação do linfoma em gatos e sua relação com a detecção do DNA pró-viral do vírus da leucemia felina

In this retrospective and prospective study, histopathological and immunohistochemical analyses of 62 cases of lymphomas in cats were performed to classify the anatomic forms and subtypes, according to the WHO guidelines, and correlate it to FeLV proviral DNA detected using PCR. The most common anatomical form was gastrointestinal (40.3%, 25/62), followed by multicentric (29%, 18/62), mediastinal (17.7%, 11/62) and extranodal (12,9%, 8/62). Among the lymphoma subtypes, diffuse large B-cell lymphoma (DLBCL) (30.6%, 19/62) was the most commonly diagnosed followed by peripheral T-cell lymphoma (PTCL) (29%, 18/62) and enteropathy associated T-cell lymphoma type 2 (14.5%, 9/62). DNA extraction from paraffin-embedded neoplastic tissue was obtained in 28 cases and FeLV proviral DNA was detected by PCR, in 23 of these. Of the cases presenting with FeLV proviral DNA, nine (32%) were of the multicentric form, five (22%) of the mediastinal and extranodal forms and four (17%) of the gastrointestinal form. The most frequent subtypes with FeLV proviral DNA, independent of the anatomical form, were DLBCL (39.1%, 9/23) and PTCL (34.7%, 8/23). The presence of the FeLV proviral DNA in 23 cats of this study, probably had association with the multicentric form of lymphoma and higher occurrence in the DLBCL and PTCL subtypes.

Neste estudo retrospectivo e prospectivo, análises histopatológicas e imuno-histoquímicas de 62 casos de linfomas em gatos foram realizadas para classificar as formas anatômicas o e subtipos do linfoma, de acordo com as diretrizes da OMS. Além disso, foi realizada a extração de DNA dos tumores incluídos na parafina para obtenção de DNA pró-viral do FeLV por PCR, e relacionada com os exames anteriores. A forma anatômica mais comum foi a gastrointestinal (40.3%, 25/62), seguida pela multicêntrica (29%, 18/62), mediastinal (17,7%, 11/62) e extranodal (12,9%, 8/62). Entre os subtipos de linfoma, o linfoma difuso de grandes células B (DLBCL) (30.6%, 19/62) foi o mais comumente diagnosticado, seguido por linfoma de células T periférico (PTCL) (29%, 18/62) e o linfoma de células T associado a enteropatia tipo 2 (14.5%, 9/62). A extração de DNA de tecido neoplásico emblocado em parafina foi obtida em 28 casos e o DNA pró-viral de FeLV foi detectado por PCR, em 23 deles. Dos casos com DNA pró-viral do FeLV, nove (32%) eram da forma multicêntrica, cinco (22%) das formas mediastinal e extranodal e quatro (17%) da forma gastrointestinal. Os subtipos mais frequentes com DNA pró-viral do FeLV, independente da forma anatômica, foram DLBCL (39.1%, 9/23) e PTCL (34.7%, 8/23). A presença do DNA pró-viral do FeLV em 23 gatos deste estudo, provavelmente teve associação com a forma multicêntrica do linfoma e maior ocorrência nos subtipos DLBCL e PTCL.

Prognostic impact of alterations in E-cadherin and P-cadherin expression in canine mammary tumors

A expressão de caderinas tem sido correlacionada ao desenvolvimento e agressividade de neoplasias epiteliais, entretanto, em tumores mamários caninos, seu prognóstico de importância é incerto. Devido a esse fato, a expressão das moléculas de adesão intracelular E e P-caderina e a correlação com a sobrevida global foram analisadas em 25 tumores de glândula mamária canina. A redução da expressão da caderina-E foi correlacionada com o tipo histológico, alto grau histológico e taxa de sobrevida global. A coloração de P-caderina foi maior em tumores malignos, sem relação com outras características clínico-patológicas de agressividade. Os resultados deste estudo sugerem uma relação entre menor expressão de E e P-caderina e pior prognóstico em tumores mamários caninos, incluindo menor sobrevida global.

Prognostic impact of alterations in E-cadherin and P-cadherin expression in canine mammary tumors

A expressão de caderinas tem sido correlacionada ao desenvolvimento e agressividade de neoplasias epiteliais, entretanto, em tumores mamários caninos, seu prognóstico de importância é incerto. Devido a esse fato, a expressão das moléculas de adesão intracelular E e P-caderina e a correlação com a sobrevida global foram analisadas em 25 tumores de glândula mamária canina. A redução da expressão da caderina-E foi correlacionada com o tipo histológico, alto grau histológico e taxa de sobrevida global. A coloração de P-caderina foi maior em tumores malignos, sem relação com outras características clínico-patológicas de agressividade. Os resultados deste estudo sugerem uma relação entre menor expressão de E e P-caderina e pior prognóstico em tumores mamários caninos, incluindo menor sobrevida global.(AU)

Clinical, histopathological and immunohistochemical features ofa thymoma in a domestic rabbit (Oryctolagus cuniculus): casereport

Thymoma is a neoplasm originating from epithelial cells of the thymus. It represents the most common tumor in the mediastinal region of rabbits, followed by lymphoma. This study aims to report a case of post mortem diagnosis of thymoma in a rabbit (Oryctolagus cuniculus), with the purpose to contribute to the understanding of this disease and its diagnosis in this specie. A six-year-old male mixed breed pet rabbit (O. cuniculus), weighing 2.3 kg, was referred to necropsy exam. The previous clinical history included prostration, lethargy, weight loss, dysorexia and respiratory distress, evidenced mainly on the expiratory phase. Radiographs revealed pleural effusion and the presence of a mass involving the cranial and middle mediastinum, confirmed by ultrasound. In the cytological examination, it was diagnosed as a low-gradelymphoma and chemotherapy was performed with COP (cyclophosphamide, vincristine Oncovin®, prednisolone). However, after 145 days, euthanasia was performed. At necropsy, a well delimited mass was observed in the mediastinal region, adhered to the pleura, with firm consistency and pale coloration. Histopathological analysis of the mass showed the proliferation of epithelial neoplastics cells, arranged in trabeculas and with infiltration of small lymphocytes. The immunohistochemical findings included cytoplasmic immunolabeling for cytokeratin AE1/AE3 in 90% of epithelial neoplastics cells, while CD3 was evidenced in a small number of lymphocytes (T-lymphocytes) and CD79a in Blymphocytes localized on the neoplasia periphery. The growth fraction was estimated at 30% by Ki-67. According to the histopathological criteria for thymoma classification proposed by the World Health Organization, 2015, it was made the diagnosis of lymphocyte-rich predominantly cortical thymoma (B1 type).(AU)

Clinical, histopathological and immunohistochemical features ofa thymoma in a domestic rabbit (Oryctolagus cuniculus): casereport

Thymoma is a neoplasm originating from epithelial cells of the thymus. It represents the most common tumor in the mediastinal region of rabbits, followed by lymphoma. This study aims to report a case of post mortem diagnosis of thymoma in a rabbit (Oryctolagus cuniculus), with the purpose to contribute to the understanding of this disease and its diagnosis in this specie. A six-year-old male mixed breed pet rabbit (O. cuniculus), weighing 2.3 kg, was referred to necropsy exam. The previous clinical history included prostration, lethargy, weight loss, dysorexia and respiratory distress, evidenced mainly on the expiratory phase. Radiographs revealed pleural effusion and the presence of a mass involving the cranial and middle mediastinum, confirmed by ultrasound. In the cytological examination, it was diagnosed as a low-gradelymphoma and chemotherapy was performed with COP (cyclophosphamide, vincristine – Oncovin®, prednisolone). However, after 145 days, euthanasia was performed. At necropsy, a well delimited mass was observed in the mediastinal region, adhered to the pleura, with firm consistency and pale coloration. Histopathological analysis of the mass showed the proliferation of epithelial neoplastics cells, arranged in trabeculas and with infiltration of small lymphocytes. The immunohistochemical findings included cytoplasmic immunolabeling for cytokeratin AE1/AE3 in 90% of epithelial neoplastics cells, while CD3 was evidenced in a small number of lymphocytes (T-lymphocytes) and CD79a in Blymphocytes localized on the neoplasia periphery. The growth fraction was estimated at 30% by Ki-67. According to the histopathological criteria for thymoma classification proposed by the World Health Organization, 2015, it was made the diagnosis of lymphocyte-rich predominantly cortical thymoma (B1 type).

Consensus Regarding the Diagnosis, Prognosis and Treatment of Canine and Feline Mammary Tumors 2019

The aim of this paper is to discuss and update criteria that can guide the diagnosis, prognosis and treatment of canine and feline mammary neoplasms. It was elaborated during the IV Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment of the Canine and Feline Mammary Neoplasia, held on April 29th and 30th, 2019 in Belo Horizonte MG, Brazil, sponsored by the Laboratory of Comparative Pathology of the Federal University of Minas Gerais (UFMG), with the support of the Brazilian Association of Veterinary Pathology (ABPV) and Brazilian Association of Veterinary Oncology (ABROVET). Academics from several regions of Brazil were present and contributed to this work.(AU)

Consensus Regarding the Diagnosis, Prognosis and Treatment of Canine and Feline Mammary Tumors – 2019

The aim of this paper is to discuss and update criteria that can guide the diagnosis, prognosis and treatment of canine and feline mammary neoplasms. It was elaborated during the IV Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment of the Canine and Feline Mammary Neoplasia, held on April 29th and 30th, 2019 in Belo Horizonte – MG, Brazil, sponsored by the Laboratory of Comparative Pathology of the Federal University of Minas Gerais (UFMG), with the support of the Brazilian Association of Veterinary Pathology (ABPV) and Brazilian Association of Veterinary Oncology (ABROVET). Academics from several regions of Brazil were present and contributed to this work.

Diffuse thoracic and peritoneal papillary mesothelioma in an adult cow: case report

Mesothelioma is a rare tumor of mesothelium and usually spread by implantation in the same cavity it arises. Regarding bovine mesotheliomas, the abdominal cavity is the most affected site. This article describes a case of diffuse papillary mesothelioma within both thoracic and abdominal cavity with nodal metastasis in an adult cow – based on cytology, histopathology, and immunohistochemical analysis. A 7-years-old cow, Nelore breed (Brazilian beef cattle), with clinical signs of tachypnea, abdominal distention, and positive jugular venous pulse was slaughtered and necropsied due to persistent weight loss. The main gross findings were several verrucous and yellowish nodules spread on pericardium, pleura, and peritoneum. Mediastinal lymph nodes were enlarged and hemorrhagic with multiples yellowish spots on cut surface. The diagnoses of diffuse mesothelioma with nodal metastasis was established and ratified by the microscopic analysis. Immunohistochemical results had strong positivity for cytokeratin and the Ki-67 showed proliferative index of 28%. Vimentin was positive only in the cells of fibrous tissue. In this case, the initial site of the mesothelioma was not recognized. Although it is a post-mortem study, cytology may be very helpful in vivo investigation. Equally important, is the IHC to better comprehend this tumor and its behavior.

Diffuse thoracic and peritoneal papillary mesothelioma in an adult cow: case report

Mesothelioma is a rare tumor of mesothelium and usually spread by implantation in the same cavity it arises. Regarding bovine mesotheliomas, the abdominal cavity is the most affected site. This article describes a case of diffuse papillary mesothelioma within both thoracic and abdominal cavity with nodal metastasis in an adult cow based on cytology, histopathology, and immunohistochemical analysis. A 7-years-old cow, Nelore breed (Brazilian beef cattle), with clinical signs of tachypnea, abdominal distention, and positive jugular venous pulse was slaughtered and necropsied due to persistent weight loss. The main gross findings were several verrucous and yellowish nodules spread on pericardium, pleura, and peritoneum. Mediastinal lymph nodes were enlarged and hemorrhagic with multiples yellowish spots on cut surface. The diagnoses of diffuse mesothelioma with nodal metastasis was established and ratified by the microscopic analysis. Immunohistochemical results had strong positivity for cytokeratin and the Ki-67 showed proliferative index of 28%. Vimentin was positive only in the cells of fibrous tissue. In this case, the initial site of the mesothelioma was not recognized. Although it is a post-mortem study, cytology may be very helpful in vivo investigation. Equally important, is the IHC to better comprehend this tumor and its behavior.(AU)

Tumor-associated macrophage is correlated with survival and SOCS protein expression in canine mammary carcinoma / Correlação do infiltrado macrofágico com a sobrevida e a expressão da proteína SOCS no carcinoma mamário canino

The inflammatory infiltrate in the tumor microenvironment, particularly in mammary tumors, has aroused great interest in oncology, to play different roles in the progression or tumor regression dependent on the types and cell subsets involved. The present study aimed to evaluate (1) the occurrence and intensity of macrophage infiltration in the mammary carcinoma microenvironment, (2) the expression of SOCS1 and SOCS3 proteins in tumor associated macrophages, (3) any association between these parameters and tumor development, as well as survival rates in female dogs. Twenty-two female dogs diagnosed as carcinoma arising in a mixed tumor (CMT) by histopathology were divided into two groups following mastectomy: dogs without metastasis (CMT(-)=11) and those with metastasis (CMT(+)=11). The following parameters were analyzed: tumor size, lymph node metastasis, clinical stage, histological grade, distribution and intensity of inflammatory infiltrate, tumor macrophage quantification by immunohistochemical analysis of SOCS1 and SOCS3 expression, and immunophenotyping of peripheral blood leukocytes by flow cytometry. Dogs with the higher proportions of macrophages in the inflammatory infiltrate (≥400/tumor) also had higher survival rates in comparison with dogs with less macrophages. Immunostaining revealed higher proportions of SOCS3-positive macrophages in dogs without lymph node metastasis, while SOCS1-positive macrophages were predominant in dogs with metastasis (p<0.05). Multivariate analysis found associations between survival rate and clinical staging (p=0.025), histological grade (p=0.007), and the expression of MHC-CI in circulating monocytes (p=0.018)...(AU)

O infiltrado inflamatório no microambiente tumoral, particularmente nos tumores mamários, tem despertado grande interesse na oncologia, por desempenhar diferentes funções na progressão ou regressão tumoral, dependendo dos tipos e subtipos celulares envolvidos. O presente estudo teve como objetivo avaliar: (1) a ocorrência e a intensidade do infiltrado macrofágico no microambiente do carcinoma mamário; (2) a expressão das proteínas SOCS1 e SOCS3 nos macrófagos associados ao tumor; (3) qualquer associação relacionada ao prognóstico entre estes parâmetros e o desenvolvimento tumoral, assim como a taxa de sobrevida. Vinte e duas cadelas diagnosticadas com carcinoma em tumor misto (CTM) por exame histopatológico foram divididas em dois grupos após a mastectomia: cadelas sem metástase (CTM(-)=11) e cadelas com metástase (CTM(+)=11). Foram analisados os seguintes parâmetros: tamanho do tumor, metástase para linfonodo, estadiamento clínico, grau histológico, distribuição e intensidade do infiltrado inflamatório, quantificação dos macrófagos tumorais por análise imuno-histoquímica da expressão de SOCS1 e SOCS3, e imunofenotipagem dos leucócitos (monócitos e linfócitos) do sangue periférico por citometria de fluxo. Cadelas que apresentavam maiores proporções de macrófagos no infiltrado inflamatório (≥400/tumor) também tiveram maior taxa de sobrevida em comparação àquelas com menos macrófagos. A imunomarcação revelou maiores proporções de macrófagos SOCS3-positivos em cães sem metástase para linfonodo, enquanto que macrófagos SOCS1-positivos foram predominantes naqueles com metástase (p<0,05). A análise multivariada identificou associações entre a taxa de sobrevida e o estadiamento clínico (p=0,025), grau histológico (p=0,007) e a expressão de MHC-CI em monócitos circulantes (p=0,018)...(AU)

Tumor-associated macrophage is correlated with survival and SOCS protein expression in canine mammary carcinoma / Correlação do infiltrado macrofágico com a sobrevida e a expressão da proteína SOCS no carcinoma mamário canino

The inflammatory infiltrate in the tumor microenvironment, particularly in mammary tumors, has aroused great interest in oncology, to play different roles in the progression or tumor regression dependent on the types and cell subsets involved. The present study aimed to evaluate (1) the occurrence and intensity of macrophage infiltration in the mammary carcinoma microenvironment, (2) the expression of SOCS1 and SOCS3 proteins in tumor associated macrophages, (3) any association between these parameters and tumor development, as well as survival rates in female dogs. Twenty-two female dogs diagnosed as carcinoma arising in a mixed tumor (CMT) by histopathology were divided into two groups following mastectomy: dogs without metastasis (CMT(-)=11) and those with metastasis (CMT(+)=11). The following parameters were analyzed: tumor size, lymph node metastasis, clinical stage, histological grade, distribution and intensity of inflammatory infiltrate, tumor macrophage quantification by immunohistochemical analysis of SOCS1 and SOCS3 expression, and immunophenotyping of peripheral blood leukocytes by flow cytometry. Dogs with the higher proportions of macrophages in the inflammatory infiltrate (≥400/tumor) also had higher survival rates in comparison with dogs with less macrophages. Immunostaining revealed higher proportions of SOCS3-positive macrophages in dogs without lymph node metastasis, while SOCS1-positive macrophages were predominant in dogs with metastasis (p<0.05). Multivariate analysis found associations between survival rate and clinical staging (p=0.025), histological grade (p=0.007), and the expression of MHC-CI in circulating monocytes (p=0.018). Higher SOCS3 expression in activated macrophages within the inflammatory infiltrate were considered indicative of an antitumor immune response, improved clinicopathological parameters and longer survival, whereas SOCS1-related activation was associated with tumor progression, metastasis development and reduced survival in female dogs with mammary carcinomas.(AU)

O infiltrado inflamatório no microambiente tumoral, particularmente nos tumores mamários, tem despertado grande interesse na oncologia, por desempenhar diferentes funções na progressão ou regressão tumoral, dependendo dos tipos e subtipos celulares envolvidos. O presente estudo teve como objetivo avaliar: (1) a ocorrência e a intensidade do infiltrado macrofágico no microambiente do carcinoma mamário; (2) a expressão das proteínas SOCS1 e SOCS3 nos macrófagos associados ao tumor; (3) qualquer associação relacionada ao prognóstico entre estes parâmetros e o desenvolvimento tumoral, assim como a taxa de sobrevida. Vinte e duas cadelas diagnosticadas com carcinoma em tumor misto (CTM) por exame histopatológico foram divididas em dois grupos após a mastectomia: cadelas sem metástase (CTM(-)=11) e cadelas com metástase (CTM(+)=11). Foram analisados os seguintes parâmetros: tamanho do tumor, metástase para linfonodo, estadiamento clínico, grau histológico, distribuição e intensidade do infiltrado inflamatório, quantificação dos macrófagos tumorais por análise imuno-histoquímica da expressão de SOCS1 e SOCS3, e imunofenotipagem dos leucócitos (monócitos e linfócitos) do sangue periférico por citometria de fluxo. Cadelas que apresentavam maiores proporções de macrófagos no infiltrado inflamatório (≥400/tumor) também tiveram maior taxa de sobrevida em comparação àquelas com menos macrófagos. A imunomarcação revelou maiores proporções de macrófagos SOCS3-positivos em cães sem metástase para linfonodo, enquanto que macrófagos SOCS1-positivos foram predominantes naqueles com metástase (p<0,05). A análise multivariada identificou associações entre a taxa de sobrevida e o estadiamento clínico (p=0,025), grau histológico (p=0,007) e a expressão de MHC-CI em monócitos circulantes (p=0,018). A maior expressão de SOCS3 nos macrófagos ativados foi considerada indicativa de uma resposta imune antitumoral, melhores parâmetros clínicos e maior taxa de sobrevida, ao passo que a ativação relacionada com SOCS1 foi associada à progressão tumoral, desenvolvimento de metástase e redução na taxa de sobrevida em cadelas com carcinoma mamário.(AU)

Consensus regarding the diagnosis, prognosis and treatment of canine mammary tumors: benign mixed tumors, carcinomas in mixed tumors and carcinosarcomas

Mammary neoplasms are the most frequent tumors in female dogs. Of these neoplasms, benign mixed tumors (BMTs) and carcinomas in mixed tumors (CMTs) represent a large proportion of small animal oncology diagnoses. Together with carcinosarcomas (CSs), these three neoplastic entities are characterized by the proliferation of benign or malignant epithelial, myoepithelial, and mesenchymal cells, depending on their histological types. This histological heterogeneity, in addition to their molecular heterogeneity, confers these tumors with distinct biological behavior, which results in the need for different clinical and therapeutic approaches. The present consensual document elucidates the oncological issues related to the diagnosis, prognosis, and treatment of BMTs, CMTs, and CSs of the canine mammary gland.

Consensus regarding the diagnosis, prognosis and treatment of canine mammary tumors: benign mixed tumors, carcinomas in mixed tumors and carcinosarcomas

Mammary neoplasms are the most frequent tumors in female dogs. Of these neoplasms, benign mixed tumors (BMTs) and carcinomas in mixed tumors (CMTs) represent a large proportion of small animal oncology diagnoses. Together with carcinosarcomas (CSs), these three neoplastic entities are characterized by the proliferation of benign or malignant epithelial, myoepithelial, and mesenchymal cells, depending on their histological types. This histological heterogeneity, in addition to their molecular heterogeneity, confers these tumors with distinct biological behavior, which results in the need for different clinical and therapeutic approaches. The present consensual document elucidates the oncological issues related to the diagnosis, prognosis, and treatment of BMTs, CMTs, and CSs of the canine mammary gland.(AU)

Consensus for the Diagnosis, Prognosis and Treatment of Canine Mammary Tumors 2013

The purpose of this paper is to establish criteria that could guide the diagnosis, prognosis and treatment of caninemammary neoplasias. It was elaborated during the Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment ofthe Canine Mammary Neoplasia, held on November 6th and 7th, 2010 in Belo Horizonte – MG, Brazil. Academics fromseveral regions of Brazil were present and contributed to this work. After three years, a new discussion was foundnecessary in order to address important questions: 1 - Have Brazilian DVMs applied the consensus? 2 - What were the maindifficulties in applying the consensus? 3 - What were the obtained results? 4 - What were the main differences among thevarious oncology services/groups? 5 - How could the criteria be improved and uniformed? A spreadsheet that allowed datacollection and an abstract was submitted by each oncology service/group from various parts of the country. Based on theabstracts we identified the main differences in diagnosis and therapeutic conducts among the groups. These differences haveguided the discussions of the II Mammary Pathology Meeting and the publication of a second consensus that has beenrevised and updated. The II Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment of the Canine mamaryNeoplasia, was held on December 9th, 10thand 11th, 2013 in Belo Horizonte – MG, sponsored by the Laboratory ofComparative Pathology of the Federal University of Minas Gerais (UFMG), with the support of the Brazilian Associationof Veterinary Pathology (ABPV) and Brazilian Association of Veterinary Oncology (ABROVET). Academics from severalregions of Brazil were present and contributed to this work.

Consensus for the Diagnosis, Prognosis and Treatment of Canine Mammary Tumors 2013

The purpose of this paper is to establish criteria that could guide the diagnosis, prognosis and treatment of caninemammary neoplasias. It was elaborated during the Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment ofthe Canine Mammary Neoplasia, held on November 6th and 7th, 2010 in Belo Horizonte MG, Brazil. Academics fromseveral regions of Brazil were present and contributed to this work. After three years, a new discussion was foundnecessary in order to address important questions: 1 - Have Brazilian DVMs applied the consensus? 2 - What were the maindifficulties in applying the consensus? 3 - What were the obtained results? 4 - What were the main differences among thevarious oncology services/groups? 5 - How could the criteria be improved and uniformed? A spreadsheet that allowed datacollection and an abstract was submitted by each oncology service/group from various parts of the country. Based on theabstracts we identified the main differences in diagnosis and therapeutic conducts among the groups. These differences haveguided the discussions of the II Mammary Pathology Meeting and the publication of a second consensus that has beenrevised and updated. The II Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment of the Canine mamaryNeoplasia, was held on December 9th, 10thand 11th, 2013 in Belo Horizonte MG, sponsored by the Laboratory ofComparative Pathology of the Federal University of Minas Gerais (UFMG), with the support of the Brazilian Associationof Veterinary Pathology (ABPV) and Brazilian Association of Veterinary Oncology (ABROVET). Academics from severalregions of Brazil were present and contributed to this work.(AU)

Consensus for the Diagnosis, Prognosis and Treatment of Canine Mammary Tumors

The purpose of this paper is to establish criteria that could guide the diagnosis, prognosis and treatment of canine mammary neoplasias. It was elaborated during the Mammary Pathology Meeting: Diagnosis, Prognosis and Treatment of the Canine Mammary Neoplasm, held on November 6th and 7th, 2010 in Belo Horizonte ­ MG, Brazil, sponsored by the Laboratory of Comparative Pathology ­ UFMG, with the support of the Brazilian Association of Veterinary Pathology (ABPV) and Brazilian Association of Veterinary Oncology (ABROVET). Academics from several regions of Brazil were present and contributed to this work.(AU)

Expressão da COX-2 nos carcinomas mamários de cadelas / Expression of COX-2 in canine mammary tumors

Na cadela, a freqüência dos tumores mamários espontâneos é duas a três vezes superior à observada na mulher. A identificação de marcadores tumorais é um método valioso para predizer o comportamento da neoplasia e determinar o prognóstico da doença. Alguns trabalhos relacionam a elevada expressão da ciclooxigenase-2 (COX-2) ao aumento da capacidade proliferativa das células neoplásicas, diminuição da taxa apoptótica, e neovascularização, fatores que indiscutivelmente ampliam o potencial metastático das células tumorais, representando um prognóstico extremamente desfavorável. Foram selecionadas e acompanhadas 30 cadelas apresentando neoplasia mamária atendidas do HOSPMEV-UFBA no período de agosto/2007 a Junho/2008. Foi realizado o esta¬diamento clínico, classificação e graduação histológica e imunomarcação para COX-2. A partir do diagnóstico histopatológico, os animais foram divididos em dois grupos: carcinoma evoluindo em tumor misto benigno (CATMB) e outros carcinomas (CA). Foi observada uma freqüência signi¬ficativamente maior de CATMB. A comparação da imunomarcação ainda que maior no segundo grupo, não apresentou diferença estatisticamente significativa. A COX-2 apresentou correlação significativa e positiva com tamanho tumoral (p=0,042) e envolvimento linfonodal (p=0,005). A maior taxa de sobrevida global foi observada em cadelas cujos tumores apresentavam menor quantidade de células positivas para COX-2. Com base nos resultados observados podemos concluir que a COX-2 apresenta-se como um marcador potencial para câncer de mama da cadela trazendo perspectivas para desenvolvimento de novas terapias anti-tumorais

In the female dog, the frequency of the spontaneous mammary tumors is two to three times higher than that observed in women. The identification of tumors markers is a valuable method for predicting the behavior of the tumor and determine the prognosis of the disease. Some studies relate the high expression of ciclooxigenase-2 (COX-2) to the increase of the proliferation capacity of the cancer cells, decrease apoptosis and angiogenesis, factors which undoubtedly increased the metastatic potential of tumors cells, representing an extremely poor prognosis. Were selected and monitored 30 female dog with mammary cancer attended the UFBA HOSPMEV-in period of August/2007 to June/2008. Were carried clinical tumor evolution, classification and histological grade and immunoreactive for COX-2. From the histopathologic diagnosis, the animals were divided into two groups: carcinomas develop in benign mixed tumor (CATMB) and other carcinomas (CA). There was a significantly higher frequency of CATMB. A comparison of immunoreactive even higher in the second group, showed no statistically significant difference. COX-2 showed significant and positive correlation with tumor size (p = 0.042) and lymph node involvement (p = 0005). The highest rate of overall survival was observed in bitches whose tumors had fewer cells positive for COX-2. Based on the observed results can conclude that the COX-2 is a potential marker for breast cancer the dog bringing new prospects for development of anti-tumor therapy

Expressão da COX-2 nos carcinomas mamários de cadelas / Expression of COX-2 in canine mammary tumors

Na cadela, a freqüência dos tumores mamários espontâneos é duas a três vezes superior à observada na mulher. A identificação de marcadores tumorais é um método valioso para predizer o comportamento da neoplasia e determinar o prognóstico da doença. Alguns trabalhos relacionam a elevada expressão da ciclooxigenase-2 (COX-2) ao aumento da capacidade proliferativa das células neoplásicas, diminuição da taxa apoptótica, e neovascularização, fatores que indiscutivelmente ampliam o potencial metastático das células tumorais, representando um prognóstico extremamente desfavorável. Foram selecionadas e acompanhadas 30 cadelas apresentando neoplasia mamária atendidas do HOSPMEV-UFBA no período de agosto/2007 a Junho/2008. Foi realizado o esta¬diamento clínico, classificação e graduação histológica e imunomarcação para COX-2. A partir do diagnóstico histopatológico, os animais foram divididos em dois grupos: carcinoma evoluindo em tumor misto benigno (CATMB) e outros carcinomas (CA). Foi observada uma freqüência signi¬ficativamente maior de CATMB. A comparação da imunomarcação ainda que maior no segundo grupo, não apresentou diferença estatisticamente significativa. A COX-2 apresentou correlação significativa e positiva com tamanho tumoral (p=0,042) e envolvimento linfonodal (p=0,005). A maior taxa de sobrevida global foi observada em cadelas cujos tumores apresentavam menor quantidade de células positivas para COX-2. Com base nos resultados observados podemos concluir que a COX-2 apresenta-se como um marcador potencial para câncer de mama da cadela trazendo perspectivas para desenvolvimento de novas terapias anti-tumorais(AU)

In the female dog, the frequency of the spontaneous mammary tumors is two to three times higher than that observed in women. The identification of tumors markers is a valuable method for predicting the behavior of the tumor and determine the prognosis of the disease. Some studies relate the high expression of ciclooxigenase-2 (COX-2) to the increase of the proliferation capacity of the cancer cells, decrease apoptosis and angiogenesis, factors which undoubtedly increased the metastatic potential of tumors cells, representing an extremely poor prognosis. Were selected and monitored 30 female dog with mammary cancer attended the UFBA HOSPMEV-in period of August/2007 to June/2008. Were carried clinical tumor evolution, classification and histological grade and immunoreactive for COX-2. From the histopathologic diagnosis, the animals were divided into two groups: carcinomas develop in benign mixed tumor (CATMB) and other carcinomas (CA). There was a significantly higher frequency of CATMB. A comparison of immunoreactive even higher in the second group, showed no statistically significant difference. COX-2 showed significant and positive correlation with tumor size (p = 0.042) and lymph node involvement (p = 0005). The highest rate of overall survival was observed in bitches whose tumors had fewer cells positive for COX-2. Based on the observed results can conclude that the COX-2 is a potential marker for breast cancer the dog bringing new prospects for development of anti-tumor therapy(AU)